表纸
市场调查报告书

第一代培养细胞的全球市场 (~2025年):各来源 (人、动物)、类型 (造血、皮肤细胞、肠胃、肝细胞、肺、肾、肌肉骨骼、心脏)、终端用户、地区

Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025

出版商 MarketsandMarkets 商品编码 963016
出版日期 内容资讯 英文 176 Pages
订单完成后即时交付
价格
第一代培养细胞的全球市场 (~2025年):各来源 (人、动物)、类型 (造血、皮肤细胞、肠胃、肝细胞、肺、肾、肌肉骨骼、心脏)、终端用户、地区 Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025
出版日期: 2020年10月01日内容资讯: 英文 176 Pages
简介

全球第一代培养细胞的市场规模在预测期间内预计以10.7%的年复合成长率发展,从2020年的9亿7000万美元,成长到2025年16亿1300万美元的规模。癌症的盛行率扩大,生物技术及生物医药品产业的急速成长,R&D的关注高涨,近几年干细胞治疗的发展,单株抗体需求增加,胜过细胞株的第一代人细胞的优点等要素促进该市场成长。

本报告提供全球第一代培养细胞的市场调查,市场定义和概要,价值链,新型冠状病毒感染疾病 (COVID-19) 以及其他的市场影响因素分析,市场规模的变化、预测,来源、类型、终端用户、地区/主要国家等各种区分的明细,竞争环境,主要企业简介等资讯汇整。

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 重要考察

第5章 市场概要

  • 市场动态
    • 促进因素
    • 限制
    • 市场机会
  • COVID-19的影响
  • 价格分析
  • 价值链分析
  • 供应链分析
  • 生态系统分析

第6章 市场分析、预测:各来源

  • 人来源
  • 动物来源

第7章 市场分析、预测:各类型

  • 造血细胞
  • 皮肤丝状真菌
  • 肠胃细胞
  • 肝细胞
    • 冻结保存肝细胞
    • 新鲜肝细胞
  • 肺细胞
  • 肾细胞
  • 心脏细胞
  • 肌肉骨骼细胞
  • 其他

第8章 市场分析、预测:各终端用户

  • 生命科学研究企业
  • 研究机关

第9章 市场分析、预测:各地区、主要国家

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 其他
  • 亚太地区
    • 中国
    • 日本
    • 其他
  • 其他地区

第10章 竞争情形

  • 概要
  • 市场占有率分析
  • 竞争模式

第11章 企业评估矩阵、企业简介

  • 企业评估矩阵:定义、调查手法
  • 新兴企业:竞争领导制图
  • 企业简介
    • THERMO FISHER SCIENTIFIC, INC.
    • MERCK KGAA
    • LONZA
    • PROMOCELL GMBH
    • CORNING INCORPORATED
    • AMERICAN TYPE CULTURE COLLECTION (ATCC)
    • CELL BIOLOGICS, INC.
    • HEMACARE CORPORATION (A CHARLES RIVER LABORATORIES, INC. COMPANY)
    • ZENBIO, INC.
    • STEM CELL TECHNOLOGIES, INC.
    • ALLCELLS
    • AXOL BIOSCIENCE LTD.
    • IXCELLS BIOTECHNOLOGIES
    • NEUROMICS
    • STEMEXPRESS
    • BIOIVT
    • SCIENCELL RESEARCH LABORATORIES, INC.
    • SEKISUI XENOTECH, LLC
    • PPA RESEARCH GROUP, INC.
    • CREATIVE BIOARRAY
    • BPS BIOSCIENCE, INC.
    • EPITHELIX SARL
    • REACHBIO LLC
    • ACCEGEN
    • BIOPREDIC INTERNATIONAL

第12章 附录

目录
Product Code: BT 6489

The global primary cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7% during the forecast period. Market growth is driven by the rising prevalence of cancer, the rapid growth in the biotechnology & biopharmaceutical industries, growing focus on R&D, recent developments in stem cell therapy, the increasing demand for monoclonal antibodies, and advantages of primary human cells over cell lines are the major factors driving the growth of the primary cells market.

"The human primary cells accounted for the highest growth rate in the primary cells market, by origin, during the forecast period"

Based on origin, the primary cells market is segmented into human and animal primary cells. The human primary cells segment accounted for the highest growth rate in the primary cells market in 2019. The increasing funding for the R&D of regenerative therapies, the rising incidence of cancer, and the growing application areas of human stem cells are the major factors driving the growth of this segment.

"Hepatocytes segment accounted for the highest CAGR"

Based on type, the primary cells market is segmented into hematopoietic cells, dermatocytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and other primary cells. In 2019, the hepatocytes segment accounted for the highest growth rate. Increasing research funding by key pharma players, increasing incidence of liver cancer & pediatric liver diseases across the globe, and the emergence of new companies dedicated to liver therapeutics research are the major factors driving the growth of this segment.

"Life science research companies segment accounted for the highest CAGR"

Based on end-users, the primary cells market is segmented into life science research companies and research institutes. In 2019, the life science research companies segment accounted for the highest growth rate. This can be attributed to the increasing investments of companies in cell-based research, high adoption of primary cells in cell-based experiments, increasing cancer research in life science research companies, and the increasing number of R&D facilities globally.

"Asia Pacific: The fastest-growing region primary cells market"

The global primary cells market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period in 2019. The growth in this region can be attributed to the increasing research activities in Asian countries, the availability of funding for research, a growing number of biobanks & research centers, rising prevalence of cancer, and recent developments in tissue engineering & stem cell therapy.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
  • By Designation: C-level - 30%, D-level - 20%, and Others - 50%
  • By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, and Rest of the World - 12%

Lits of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc. (US)
  • Merck KGaA (Germany)
  • Lonza (Switzerland)
  • Cell Biologics, Inc. (US)
  • PromoCell GmbH (Germany)
  • HemaCare Corporation (US)
  • ZenBio, Inc. (US)
  • STEMCELL Technologies, Inc. (Canada)
  • Corning Incorporated (US)
  • AllCells (US)
  • American Type Culture Collection (US)
  • Axol Bioscience Ltd. (UK)
  • iXCells Biotechnologies (US)
  • Neuromics (US)
  • StemExpress (US)
  • BioIVT (US)
  • ScienCell Research Laboratories, Inc. (US)
  • PPA Research Group, Inc. (US)
  • Creative Bioarray (US)
  • BPS Bioscience, Inc. (US)
  • Epithelix Sarl (Switzerland)
  • ReachBio LLC (US)
  • AcceGen (US)
  • Sekisui XenoTech, LLC (US)
  • Biopredic International (France).

Research Coverage:

This report provides a detailed picture of the global primary cells market. It aims at estimating the size and future growth potential of the market across different segments, such as origin, type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall primary cells market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 PRIMARY CELLS MARKET
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 REPORT COMPARISON WITH THE JULY 2018 EDITION
    • 1.6.1 SUMMARY OF CHANGES
    • 1.6.2 LIMITATIONS OF THE CURRENT EDITION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 PRIMARY CELLS MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
      • 2.2.2.1 Key data from primary sources
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 4 PRIMARY CELLS MARKET: BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 5 PRIMARY CELLS MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 7 PRIMARY CELLS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 PRIMARY CELLS MARKET, BY ORIGIN, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 PRIMARY CELLS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 PRIMARY CELLS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 PRIMARY CELLS MARKET OVERVIEW
    • FIGURE 11 INCREASING CANCER RESEARCH IS DRIVING THE GROWTH OF THE PRIMARY CELLS MARKET
  • 4.2 PRIMARY CELLS MARKET, BY ORIGIN, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 HUMAN PRIMARY CELLS SEGMENT TO DOMINATE THE MARKET IN 2020
  • 4.3 PRIMARY CELLS MARKET SHARE, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 13 LIFE SCIENCE RESEARCH COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE PRIMARY CELLS MARKET DURING THE FORECAST PERIOD
  • 4.4 PRIMARY CELLS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE PRIMARY CELLS MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 15 PRIMARY CELLS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing cancer research
    • TABLE 1 PROJECTED INCREASE IN THE NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2035
    • TABLE 2 RESEARCH FUNDING FOR NATIONAL CANCER INSTITUTE, 2015 VS. 2017 (USD MILLION)
      • 5.2.1.2 Advantages of primary human cells over cell lines
      • 5.2.1.3 Increasing demand for monoclonal antibodies
      • 5.2.1.4 Rapid growth in the biotechnology and biopharmaceutical industries
    • FIGURE 16 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017-2024
      • 5.2.1.5 Growing focus on personalized medicine
    • TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008-2016
      • 5.2.1.6 Government investments for cell-based research
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Concerns regarding primary cell culture contamination
      • 5.2.2.2 Ethical concerns regarding research in cell biology
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Advancing biomedical research using primary cells in 3D cultures
  • 5.3 COVID-19 IMPACT ON THE PRIMARY CELLS MARKET
  • 5.4 PRICING ANALYSIS
    • TABLE 4 PRICE OF PRIMARY CELLS (2020)
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 18 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.7 ECOSYSTEM ANALYSIS OF THE PRIMARY CELLS MARKET
    • FIGURE 19 ECOSYSTEM ANALYSIS OF THE PRIMARY CELLS MARKET

6 PRIMARY CELLS MARKET, BY ORIGIN

  • 6.1 INTRODUCTION
    • TABLE 5 PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
  • 6.2 HUMAN PRIMARY CELLS
    • 6.2.1 INCREASING PREVALENCE OF CANCER TO SUPPORT MARKET GROWTH
    • TABLE 6 HUMAN PRIMARY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 6.3 ANIMAL PRIMARY CELLS
    • 6.3.1 RISING INVESTMENTS IN ANIMAL CELL RESEARCH TO PROPEL THE MARKET GROWTH
    • TABLE 7 ANIMAL PRIMARY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)

7 PRIMARY CELLS MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 8 PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 7.2 HEMATOPOIETIC CELLS
    • 7.2.1 INCREASING CANCER RESEARCH & FUNDING TO PROPEL THE MARKET GROWTH
    • TABLE 9 HEMATOPOIETIC CELLS, BY TYPE
    • TABLE 10 HEMATOPOIETIC CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 11 NORTH AMERICA: HEMATOPOIETIC CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 12 EUROPE: HEMATOPOIETIC CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 13 ASIA PACIFIC: HEMATOPOIETIC CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.3 DERMATOCYTES
    • 7.3.1 RISING PREVALENCE OF MELANOMA IS A KEY FACTOR DRIVING THE GROWTH OF THIS SEGMENT
    • TABLE 14 DERMATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 15 NORTH AMERICA: DERMATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 16 EUROPE: DERMATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 17 ASIA PACIFIC: DERMATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.4 GASTROINTESTINAL CELLS
    • 7.4.1 INCREASING INCIDENCE OF STOMACH CANCER TO BOLSTER MARKET GROWTH
    • TABLE 18 GASTROINTESTINAL CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 19 NORTH AMERICA: GASTROINTESTINAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 20 EUROPE: GASTROINTESTINAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: PRIMARY GASTROINTESTINAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.5 HEPATOCYTES
    • TABLE 22 GLOBAL LIVER DISORDER INCIDENCE
    • TABLE 23 HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 24 HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 25 NORTH AMERICA: HEPATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 26 EUROPE: HEPATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 27 ASIA PACIFIC: HEPATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 7.5.1 CRYOPRESERVED HEPATOCYTES
      • 7.5.1.1 Longer lifespan of cryopreserved hepatocytes than fresh hepatocytes to drive market growth
    • TABLE 28 CRYOPRESERVED HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 7.5.2 FRESH HEPATOCYTES
      • 7.5.2.1 Stringent regulations and limited availability of fresh hepatocytes to limit market growth
    • TABLE 29 FRESH HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.6 LUNG CELLS
    • 7.6.1 INCREASING RATE OF LUNG CANCER & COPD TO DRIVE THE DEMAND FOR LUNG CELLS
    • TABLE 30 LUNG CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 31 NORTH AMERICA: LUNG CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 32 EUROPE: LUNG CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 33 ASIA PACIFIC: LUNG CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.7 RENAL CELLS
    • 7.7.1 LACK OF AVAILABILITY OF EFFECTIVE RENAL THERAPIES TO PROPEL MARKET GROWTH
    • TABLE 34 RENAL CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 35 NORTH AMERICA: RENAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 36 EUROPE: RENAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: RENAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.8 HEART CELLS
    • 7.8.1 HIGH INCIDENCE OF CARDIOVASCULAR DISEASES IS SUPPORTING THE GROWTH OF THIS SEGMENT
    • TABLE 38 HEART CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 39 NORTH AMERICA: HEART CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 40 EUROPE: HEART CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 41 ASIA PACIFIC: HEART CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.9 MUSCULOSKELETAL CELLS
    • 7.9.1 RISING INCIDENCE OF MUSCULOSKELETAL DISORDERS TO PROPEL MARKET GROWTH
    • TABLE 42 MUSCULOSKELETAL CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 43 NORTH AMERICA: MUSCULOSKELETAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 44 EUROPE: MUSCULOSKELETAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: MUSCULOSKELETAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.10 OTHER PRIMARY CELLS
    • TABLE 46 OTHER PRIMARY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 47 NORTH AMERICA: OTHER PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 48 EUROPE: OTHER PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: OTHER PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

8 PRIMARY CELLS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 50 PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 8.2 LIFE SCIENCE RESEARCH COMPANIES
    • 8.2.1 INCREASING INVESTMENTS IN CELL-BASED RESEARCH TO DRIVE THE MARKET GROWTH
    • TABLE 51 PRIMARY CELLS MARKET FOR LIFE SCIENCE RESEARCH COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 RESEARCH INSTITUTES
    • 8.3.1 INCREASING GOVERNMENT FUNDING FOR RESEARCH AND HIGH PREVALENCE OF CANCER ARE DRIVING MARKET GROWTH
    • TABLE 52 PRIMARY CELLS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)

9 PRIMARY CELLS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 53 PRIMARY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 20 NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012-2035
    • FIGURE 21 NORTH AMERICA: PRIMARY CELLS MARKET SNAPSHOT
    • TABLE 54 NORTH AMERICA: PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 55 NORTH AMERICA: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 56 NORTH AMERICA: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 57 NORTH AMERICA: HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 58 NORTH AMERICA: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 High R&D spending and growing support for stem cell research to drive market growth in the US
    • FIGURE 22 US: CANCER INCIDENCE & MORTALITY, 2012-2035
    • TABLE 59 US: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 60 US: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 61 US: HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 62 US: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Presence of advanced R&D infrastructure to drive market growth
    • TABLE 63 CANADA: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 64 CANADA: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 65 CANADA: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.3 EUROPE
    • FIGURE 23 EUROPE: CANCER INCIDENCE & MORTALITY, 2012-2035
    • TABLE 66 EUROPE: PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 67 EUROPE: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 68 EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 69 EUROPE: HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 70 EUROPE: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.1 UK
      • 9.3.1.1 Growth in the life sciences industry to drive market growth in the UK
    • TABLE 71 UK: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 72 UK: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 73 UK: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Increasing life science research activities to support market growth
    • TABLE 74 GERMANY: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 75 GERMANY: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 76 GERMANY: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Robust biotechnology infrastructure in the country to support market growth
    • TABLE 77 FRANCE: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 78 FRANCE: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 79 FRANCE: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Increasing number of cell biology seminars and conferences to fuel the adoption of primary cells
    • TABLE 80 ITALY: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 81 ITALY: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 ITALY: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.5 REST OF EUROPE
    • TABLE 83 ROE: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 84 ROE: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 85 ROE: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: CANCER INCIDENCE & MORTALITY, 2012-2035
    • FIGURE 25 ASIA PACIFIC: PRIMARY CELLS MARKET SNAPSHOT
    • TABLE 86 APAC: PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 87 APAC: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 88 APAC: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 89 APAC: HEPATOCYTES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 90 APAC: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 Growing focus on cancer therapeutics-related research to bolster market growth
    • TABLE 91 CHINA: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 92 CHINA: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 93 CHINA: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Government initiatives to propel market growth in Japan
    • TABLE 94 JAPAN: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 95 JAPAN: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 96 JAPAN: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.3 REST OF ASIA PACIFIC
    • TABLE 97 ROAPAC: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 98 ROAPAC: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 99 ROAPAC: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • TABLE 100 ROW: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • TABLE 101 ROW: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 102 ROW: HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 103 ROW: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 26 KEY DEVELOPMENTS IN THE PRIMARY CELLS MARKET (2017 TO 2020)
  • 10.2 MARKET SHARE ANALYSIS
    • FIGURE 27 PRIMARY CELLS MARKET SHARE, BY KEY PLAYER (2019)
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 PRODUCT LAUNCHES
    • TABLE 104 PRODUCT LAUNCHES
    • 10.3.2 AGREEMENTS
    • TABLE 105 AGREEMENTS
    • 10.3.3 EXPANSIONS
    • TABLE 106 EXPANSIONS
    • 10.3.4 PARTNERSHIPS
    • TABLE 107 PARTNERSHIPS
    • 10.3.5 ACQUISITIONS
    • TABLE 108 ACQUISITIONS

11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

  • 11.1 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
    • 11.1.1 VENDOR EXCLUSION CRITERIA
    • 11.1.2 STARS
    • 11.1.3 EMERGING LEADERS
    • 11.1.4 PERVASIVE PLAYERS
    • 11.1.5 PARTICIPANTS
    • FIGURE 28 PRIMARY CELLS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
  • 11.2 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2019)
    • 11.2.1 PROGRESSIVE COMPANIES
    • 11.2.2 STARTING BLOCKS
    • 11.2.3 RESPONSIVE COMPANIES
    • 11.2.4 DYNAMIC COMPANIES
    • FIGURE 29 PRIMARY CELLS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2019
  • 11.3 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)**

    • 11.3.1 THERMO FISHER SCIENTIFIC, INC.
    • FIGURE 30 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
    • 11.3.2 MERCK KGAA
    • FIGURE 31 MERCK KGAA: COMPANY SNAPSHOT (2019)
    • 11.3.3 LONZA
    • FIGURE 32 LONZA: COMPANY SNAPSHOT (2019)
    • 11.3.4 PROMOCELL GMBH
    • 11.3.5 CORNING INCORPORATED
    • FIGURE 33 CORNING INCORPORATED: COMPANY SNAPSHOT (2019)
    • 11.3.6 AMERICAN TYPE CULTURE COLLECTION (ATCC)
    • 11.3.7 CELL BIOLOGICS, INC.
    • 11.3.8 HEMACARE CORPORATION (A CHARLES RIVER LABORATORIES, INC. COMPANY)
    • FIGURE 34 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
    • 11.3.9 ZENBIO, INC.
    • 11.3.10 STEM CELL TECHNOLOGIES, INC.
    • 11.3.11 ALLCELLS
    • 11.3.12 AXOL BIOSCIENCE LTD.
    • 11.3.13 IXCELLS BIOTECHNOLOGIES
    • 11.3.14 NEUROMICS
    • 11.3.15 STEMEXPRESS
    • 11.3.16 BIOIVT
    • 11.3.17 SCIENCELL RESEARCH LABORATORIES, INC.
    • 11.3.18 SEKISUI XENOTECH, LLC
    • 11.3.19 PPA RESEARCH GROUP, INC.
    • 11.3.20 CREATIVE BIOARRAY
    • 11.3.21 BPS BIOSCIENCE, INC.
    • 11.3.22 EPITHELIX SARL
    • 11.3.23 REACHBIO LLC
    • 11.3.24 ACCEGEN
    • 11.3.25 BIOPREDIC INTERNATIONAL

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS